US2023068363A1PendingUtilityA1

Compositions and formulations including cabazitaxel and human serum albumin

Assignee: ZHUHAI BEIHAI BIOTECH CO LTDPriority: Jan 15, 2016Filed: Oct 26, 2022Published: Mar 2, 2023
Est. expiryJan 15, 2036(~9.4 yrs left)· nominal 20-yr term from priority
Inventors:Qun Sun
A61K 47/42A61K 9/19A61K 31/337A61K 9/0019A61K 38/385C07D 305/14A61P 35/00A61K 9/08
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This document relates to non-covalently bound complexes comprising cabazitaxel and human serum albumin. This document also relates to compositions comprising non-covalently bound complexes comprising cabazitaxel and human serum albumin. This document also relates to compositions comprising cabazitaxel and human serum albumin. This document also relates to compositions consisting essentially of cabazitaxel and human serum albumin.

Claims

exact text as granted — not AI-modified
1 - 63 . (canceled) 
     
     
         64 . A method for the preparation of a composition comprising cabazitaxel and human serum albumin, wherein the cabazitaxel and the human serum albumin in the composition have a ratio by weight from about 1:100 to about 1:2000, said method comprising:
 (i) obtaining an organic solution of cabazitaxel in a polar water-miscible organic solvent, wherein the concentration of cabazitaxel in the organic solution is from about 0.02 mg/ml to about 20 mg/ml;   (ii) obtaining a first aqueous solution of human serum albumin, wherein the concentration of human serum albumin in the first aqueous solution is from about 0.1 mg/ml to about 100 mg/ml; and   (iii) adding the organic solution of cabazitaxel to the first aqueous solution of human serum albumin to obtain a second aqueous solution comprising the composition comprising cabazitaxel and human serum albumin, wherein the addition is done at ambient temperature.   
     
     
         65 . The method of  claim 64 , wherein the polar water-miscible organic solvent is an alcohol. 
     
     
         66 . The method of  claim 64 , wherein the polar water-miscible organic solvent is ethanol. 
     
     
         67 . The method of  claim 64 , wherein the range of pH in the second aqueous solution is from about 4 to about 8. 
     
     
         68 . The method of  claim 64 , wherein the human serum albumin is a native human serum albumin. 
     
     
         69 . The method of  claim 64 , wherein the human serum albumin is a recombinant human serum albumin.

Join the waitlist — get patent alerts

Track US2023068363A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.